EES 80 MG/ML Oral Suspension
- RxCUI
- 686418
- RxNorm name
- EES 80 MG/ML Oral Suspension
- Display name
- EES 80 MG/ML Oral Suspension
- Full name
- EES 80 MG/ML Oral Suspension
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:59
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Erythromycin ethylsuccinate | ERYTHROMYCIN ETHYLSUCCINATE | Bryant Ranch Prepack | 78139f33-0965-4bbb-a53f-6d7fd4fa9a81 | 2026-06-05 | Warnings, Adverse reactions | 686418 |
| Erythromycin ethylsuccinate | ERYTHROMYCIN ETHYLSUCCINATE | Kanchan Healthcare Inc | a7f7faaf-dc05-4d51-86c6-bf5d61562e48 | 2026-04-08 | Warnings, Adverse reactions | 686418 |
| Erythromycin Ethylsuccinate | ERYTHROMYCIN ETHYLSUCCINATE | ANI Pharmaceuticals, Inc. | 3d80f96e-3bbe-4fa5-89a8-694c61dd5e8f | 2025-06-20 | Warnings, Adverse reactions | 686418 |
| Erythromycin Ethylsuccinate | ERYTHROMYCIN | Amneal Pharmaceuticals NY LLC | 581d7430-1a80-42a6-befb-4c3ae8140392 | 2025-04-25 | Warnings, Adverse reactions | 686418 |
| Erythromycin Ethylsuccinate | ERYTHROMYCIN ETHYLSUCCINATE | Nivagen Pharmaceuticals, Inc. | 46f74c4f-10fc-44cf-aec4-d113f49149bc | 2024-01-02 | Warnings, Adverse reactions | 686418 |
| Erythromycin Ethylsuccinate | ERYTHROMYCIN | Amneal Pharmaceuticals NY LLC | 596fa019-b0eb-4e57-93ff-195a765a2e91 | 2023-12-29 | Warnings, Adverse reactions | 686418 |
| Ery-Ped | ERYTHROMYCIN ETHYLSUCCINATE | Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals) | 04775721-ab87-4b66-808c-d67a21032385 | 2023-12-16 | Warnings, Adverse reactions | 686418 |
| Erythromycin ethylsuccinate | ERYTHROMYCIN ETHYLSUCCINATE | Cadila Pharmaceuticals Limited | db70798e-5e07-41d6-afe9-82c272bc5cc0 | 2023-11-11 | Warnings, Adverse reactions | 686418 |
| ERYTHROMYCIN ETHYLSUCCINATE | ERYTHROMYCIN ETHYLSUCCINATE | Wilshire Pharmaceuticals | 86d6353c-2b58-4219-b31d-fb5b97789094 | 2020-09-24 | Warnings, Adverse reactions | 686418 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 596fa019-b0eb-4e57-93ff-195a765a2e91 | erythromycin ethylsuccinate 400 MG in 5 mL Oral Suspension [PSN] · erythromycin ethylsuccinate 80 MG/ML Oral Suspension [SCD] · EES 80 MG/ML Oral Suspension [SY] · erythromycin ethylsuccinate 400 MG per 5 ML Oral Suspension [SY] | 4 | 14 | Erythromycin Ethylsuccinate for Oral Suspension, USP, 200 mg/5 mL and 400 mg/5 mL Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin ethylsuccinate and other antibacterial drugs, erythromycin ethylsuccinate should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20231229 |
| 04775721-ab87-4b66-808c-d67a21032385 | erythromycin ethylsuccinate 400 MG in 5 mL Oral Suspension [PSN] · erythromycin ethylsuccinate 80 MG/ML Oral Suspension [SCD] · EES 80 MG/ML Oral Suspension [SY] · erythromycin ethylsuccinate 400 MG per 5 ML Oral Suspension [SY] | 4 | 12 | ERY-PED ® (ERYTHROMYCIN ETHYLSUCCINATE, USP) | 20231216 |
| a7f7faaf-dc05-4d51-86c6-bf5d61562e48 | erythromycin ethylsuccinate 400 MG in 5 mL Oral Suspension [PSN] · erythromycin ethylsuccinate 80 MG/ML Oral Suspension [SCD] · EES 80 MG/ML Oral Suspension [SY] · erythromycin ethylsuccinate 400 MG per 5 ML Oral Suspension [SY] | 4 | 7 | Erythromycin Ethylsuccinate for Oral Suspension,USP Rx only | 20260408 |
| db70798e-5e07-41d6-afe9-82c272bc5cc0 | erythromycin ethylsuccinate 400 MG in 5 mL Oral Suspension [PSN] · erythromycin ethylsuccinate 80 MG/ML Oral Suspension [SCD] · EES 80 MG/ML Oral Suspension [SY] · erythromycin ethylsuccinate 400 MG per 5 ML Oral Suspension [SY] | 4 | 5 | Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin ethylsuccinate and other antibacterial drugs, erythromycin ethylsuccinate should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20231111 |
| 3d80f96e-3bbe-4fa5-89a8-694c61dd5e8f | erythromycin ethylsuccinate 400 MG in 5 mL Oral Suspension [PSN] · erythromycin ethylsuccinate 80 MG/ML Oral Suspension [SCD] · EES 80 MG/ML Oral Suspension [SY] · erythromycin ethylsuccinate 400 MG per 5 ML Oral Suspension [SY] | 4 | 3 | Erythromycin Ethylsuccinate for Oral Suspension USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin ethylsuccinate and other antibacterial drugs, erythromycin ethylsuccinate should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20250620 |
| 86d6353c-2b58-4219-b31d-fb5b97789094 | erythromycin ethylsuccinate 400 MG in 5 mL Oral Suspension [PSN] · erythromycin ethylsuccinate 80 MG/ML Oral Suspension [SCD] · EES 80 MG/ML Oral Suspension [SY] · erythromycin ethylsuccinate 400 MG per 5 ML Oral Suspension [SY] | 4 | 3 | ERYTHROMYCIN ETHYLSUCCINATE, USP | 20200924 |
| 581d7430-1a80-42a6-befb-4c3ae8140392 | erythromycin ethylsuccinate 400 MG in 5 mL Oral Suspension [PSN] · erythromycin ethylsuccinate 80 MG/ML Oral Suspension [SCD] · EES 80 MG/ML Oral Suspension [SY] · erythromycin ethylsuccinate 400 MG per 5 ML Oral Suspension [SY] | 4 | 2 | Erythromycin Ethylsuccinate for Oral Suspension, USP 200 mg/5 mL and 400 mg/5 mL Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin ethylsuccinate and other antibacterial drugs, erythromycin ethylsuccinate should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20250425 |
| 46f74c4f-10fc-44cf-aec4-d113f49149bc | erythromycin ethylsuccinate 400 MG in 5 mL Oral Suspension [PSN] · erythromycin ethylsuccinate 80 MG/ML Oral Suspension [SCD] · EES 80 MG/ML Oral Suspension [SY] · erythromycin ethylsuccinate 400 MG per 5 ML Oral Suspension [SY] | 4 | 2 | Erythromycin Ethylsuccinate for Oral Suspension, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin ethylsuccinate for oral suspension and other antibacterial drugs, erythromycin ethylsuccinate for oral suspension should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. | 20240102 |
| 94b4658c-f4f5-4257-a1e3-82fd3155dee6 | erythromycin ethylsuccinate 400 MG in 5 mL Oral Suspension [PSN] · erythromycin ethylsuccinate 80 MG/ML Oral Suspension [SCD] · EES 80 MG/ML Oral Suspension [SY] · erythromycin ethylsuccinate 400 MG per 5 ML Oral Suspension [SY] | 4 | 1 | ERY-PED ® (ERYTHROMYCIN ETHYLSUCCINATE, USP) | 20241224 |